Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial - Kadowaki, T; Chin, R; Ozeki, A (Lancet Diabetes Endocrinol, 2022)
et al.